Senior Director, HTA, Value & Evidence Team Lead, Lung Cancer & Precision Medicine

As a leading biopharmaceutical company, Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives, and our priority is to ensure patients have access to these medicines.

The Health Technology Assessment (HTA), Value and Evidence team within Global Access & Value (GAV) organization is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions — to inform healthcare decision-making.

ROLE SUMMARY

The Senior Director, HTA, Value & Evidence (HV&E) Team Lead, Lung Cancer & Precision Medicine will report to and support the HV&E Therapeutic Area Lead for Oncology. The HV&E Team Lead, Lung Cancer & Precision Medicine directly impacts the ability to achieve business objectives by leading and managing a team of HEOR scientists to develop and implement the Value & Evidence Strategy (VES) for lung cancer and precision medicine assets/programs in alignment with the Integrated Value & Access Strategies (IVAS) and in partnership with the Global Access Strategy & Pricing Team Lead and other Oncology team members and cross-functional partners.

The HV&E Team Lead, Lung Cancer & Precision Medicine will support the HV&E Oncology Therapeutic Area Lead to drive and maintain functional excellence, VES and tactical execution and refinement, study planning and execution, talent attraction and development, and resource allocation for assets in Oncology.

She/he will supervise HEOR scientists working on cross-functional product teams, ensuring that HV&E members contribute timely, high-quality health economics and outcomes research work to those teams. She/he will ensure appropriate methods in health economics, real world evidence, outcomes research, and quality of life research are applied, in accordance with Pfizer policies.

The HV&E Team Lead, Lung Cancer & Precision Medicine will also have individual asset support responsibilities and will partner with cross-functional teams [i.e., Clinical Development, Medical Affairs, Commercial, Biostatistics, PCOA directors, and real-world evidence (RWE) scientists], and key prioritized markets to develop, implement and deliver the VES.

The HV&E Team Lead, Lung Cancer & Precision Medicine is responsible for fostering a OnePfizer mindset, promoting behaviors that exemplify Pfizer’s values (Courage, Excellence, Equity and Joy) within the team and prioritizing the development of team members’ value and evidence competencies, and talent management.

She/he will ensure there is harmonization and alignment on the VES and tactical execution within the TA programs. The HV&E Team Lead, Lung Cancer & Precision Medicine will support the HV&E Oncology Therapeutic Area Lead to partner effectively with Global Access Strategy & Pricing, Global Medical Affairs, Regulatory, Clinical Development, Commercial and prioritized country teams.  She/he will ensure engagement of key stakeholders including TA aligned business leaders on updated clinical development milestones and VES tactical plans.

ROLE RESPONSIBILITIES

• HV&E Team Lead, Lung Cancer & Precision Medicine will support the HV&E Oncology Therapeutic Area Lead to drive and maintain functional excellence, VES and tactical execution and refinement, study planning and execution, talent attraction and development, and resource allocation for assets in Oncology.

• Lead and supervise team of HV&E scientists for indications/assets, particularly in the areas listed below:
  • Generate study proposals and designs
  • Analyze, communicate, and publish impactful research to support the value proposition
  • Execute the development of comprehensive global tools such as dossiers, health economic models, publications, etc. to support optimal value and access
  • Create and update Global Value Dossiers for assigned product(s) and indications
  • Develop and utilize cost-effectiveness and health impact model(s), collaborate with country level access and value colleagues in the adaptation and utilization of the model(s) to demonstrate the public health impact and cost-effectiveness of innovative medicines
  • Assess and interpret relevant literature, communicate to internal stakeholders
  • Contribute to the VES and tactical plan development and optimization across life-cycle
  • Ensure alignment of VES with the overarching Integrated Value & Access Strategies
  • Foster a team culture that embraces collaboration, innovation, and scientific excellence with a focus on creating new capabilities to meet the needs of the evolving healthcare landscape, data generation and communication, collaboration with R&D, Clinical Development, Medical Affairs, to ensure successful commercialization and access, and talent development
  • Maintain awareness of scientific developments in assigned therapeutic area(s), new and innovative methodologies, and trends in the evolving healthcare landscape, to assure incorporation into the VES within TA
  • Build and maintain strong relationships with key partners and stakeholders (R&D, Medical Affairs, Clinical Development, Regulatory, and prioritized country access & value team) and other functions across Pfizer

• Lead the development and execution of the VES and tactics to support the value propositions of assigned assets/programs in a therapeutic area
  • Develop the strategic plan to evaluate and communicate the economic burden of disease and value drivers
  • Manage study design of contracted research projects (budget negotiations, quality assurance of work conducted by CROs)
  • Display technical competency in at least two of the following disciplines: economics, epidemiology, psychometrics, and statistics.
  • Demonstrate a technical mastery in one of the following disciplines economics, epidemiology, psychometrics, and statistics.
  • Proactively identify and address methodological issues that may affect Value & Evidence research to support Pfizer products.
  • Drive best practice sharing across the team in support of strategy development and deepening team skills and competencies
  • Recruit, manage, train, and develop HV&E personnel
  • Participate in key cross-divisional task forces to help improve processes and standards in HV&E programs
  • Help define, and ensure compliance with, state of the art health economics and outcomes research processes, tools and deliverables
  • Manage project budget and timelines
  • Some travel required in the US and/or internationally

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• Minimum Masters Degree in a relevant discipline such as, but not limited to, health services research, health outcomes research, epidemiology, pharmacy administration, public health, psychology, economics, statistics or decision sciences, plus minimum 13 years’ relevant experience in industry or consulting, or academia in HTA, HEOR, and / or market access & pricing fields.
• In depth strategic, methodologic, and technical understanding of pharmacoeconomics, health economic modeling, HTA, Health-Related Quality of Life, and / or market access dynamics
• Experience with US and EU payers
• Strong project management abilities (contracting, budgeting, vendor management)
• Excellent oral and written English communication skills

PREFERRED QUALIFICATIONS

• Strong technical and methodological skills (study design, data analysis, interpretation, communication) in clinical trials, epidemiology, or health services research, registries, Phase IV studies, technical peer review of HEOR research, observational study design and implementation is preferred.
• Recent therapeutic area experience.
• Knowledge and experience in early drug development and commercialization.
• Experience leading others (direct management or matrix leadership) with strong track record of high level of stakeholder engagement and delivering results.
• Engagement experience with HTA organizations such as ICER, NICE, SMC, PBAC
• Excellent interpersonal skills are required: ability to understand and respond to multiple internal and external customers; build strategic partnerships internally and externally.

  
Other Job Details:

• Last Date to Apply for Job: May 11th, 2024
• Position is hybrid and will require to work 2 to 3 days per week from site
• Ability to travel domestically and internationally based on business needs
• Ability to work with all US time zones
• Eligible for employee referral bonus
• Not eligible for relocation package

#LI-PFE

The annual base salary for this position ranges from $205,400.00 to $342,400.00.* In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

* The annual base salary for this position in Tampa, FL ranges from $184,900.00 to $308,100.00.

Relocation assistance may be available based on business needs and/or eligibility.

Market Access